Información del artículo
El Texto completo está disponible en PDF
Biblografía
[1.]
N.J. Talley, V. Stanghellini, R.C. Heading, et al.
Functional gastrointestinal disorders.
GUT, 45 (1999), pp. 37-42
[2.]
N.J. Talley, M.D. Silverstein, L. Agreus.
AGA technical review: Evaluation of dyspepsia. American Gastroenterological Association.
Gastroenterology, 114 (1998), pp. 582-595
[3.]
Grupo de trabajo de la guia de práctica clínica sobre la dispepsia.
Manejo del paciente con dispepsia.
[5.]
D. Guillen, K.E. McColl.
Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55?.
Am J Gastroenterol, 94 (1999), pp. 75-79
[6.]
C. Canga 3rd, N. Vakil.
Upper GI malignancy, uncoimplicated dyspepsia, and the age threshold for early endoscopy.
Am J Gastroenterol, 97 (2002), pp. 600-603
[7.]
M. Voutilainen, T. Mantynen, I. Kunnamo, et al.
Impact of clinical symptoms and referral volume on endoscopy for detecting peptic úlcer and gastric neoplasms.
Scan J Gastroenterol, 38 (2003), pp. 109-113
[8.]
M.B. Wallace, V. Durskalki, J. Vaughan.
Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study.
GUT, 49 (2001), pp. 29-34
[9.]
V. Meineche-Schmidt, T. Jorgensen.
Scand J Gastroenterol, 37 (2002), pp. 909-1007
[10.]
N.P. Breslin, A.B.R. Thomson, R.J. Bailey, et al.
Gastric cancer and other endoscopic diagnoses in patients with benign dyspepsia.
Gut, 46 (2000), pp. 93-97
[11.]
N.J. Talley, A. Axon, P. Bytzer, et al.
Manangement of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998.
Aliment Pharmacol Ther, 13 (1999), pp. 1135-1148
[12.]
J. Christie, N.A. Shepherd, B.W. Codling, R.M. Valori.
Gastric cancer below the age 55: implications for screening patients with uncomplicated dyspepsia.
GUT, 41 (1997), pp. 513-517
[13.]
M. Barenys, R. Rota, V. Moreno, et al.
Prospective validation of a clínical scoring system for the diagnosis of organic dyspepsia.
Med Clin, 121 (2003), pp. 766-771
[14.]
H.M. Sue-Ling, D. Johnston, I.G. Martin, et al.
Gastric cancer: a curable disease in Britain.
BMJ, 307 (1993), pp. 591-596
[15.]
J. Wayman, N. Hayes, S.M. Griffin.
The response of early gastric cancer to proton-pump inhibitors.
NEJM, 338 (1998), pp. 1924-1925
[16.]
J. Waymann, N. Hayes, S. Raimes.
Prescription of proton pump inhibitors before endoscopy.
Arch Fam Med, 9 (2000), pp. 385-388
[17.]
M.G. Bramble, Z. Suvakovic.
Hungin APS. Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy.
GUT, 46 (2000), pp. 464-467
[18.]
S.M. Griffin, S.A. Raimes.
Proton pump inhibitors may mask early gastric cancer.
BMJ, 317 (1998), pp. 1606-1607
[19.]
P.J. Ciclitira.
AGA Technical review on Celiac Sprue.
Gastroenterology, 120 (2001), pp. 1526-1540
[20.]
R.J. Farrell, C.P. Kelly.
Celiac sprue.
N Engl J Med, 346 (2002), pp. 180-188
[21.]
S. Vivas, J.M. Ruiz de Morales, J. Martinez, et al.
Human recombinant anti-transglutaminase antibody testing is useful in the diagnosis of silent coeliac disease in a selected group of at-risk patients.
Eur J Gastroenterol, 15 (2003), pp. 479-483
[22.]
M.N. Marsh.
Glute, major. histocompatibility complex, and the small intestine. A molecular and inmunological approach to the spectrum of gluten sensitivity (celiac sprue).
Gastroenterology, 102 (1992), pp. 330-354
[23.]
A. Tursi, G. Brandimarte.
The symptomatic and histological response to a gluten-free diet in patients with borderline enteropathy.
J Clin Gastroenterol, 36 (2003), pp. 13-17
[24.]
M. Rosinach, F. Fernandez-Bañares, M. Esteve, et al.
Gastroenterol Hepatol, (2004),
[25.]
P.J. Waham, J.B. Crusius, J.W. Meijer, C.J. Mulder.
Gluten challenge in borderline gluten sensitive enteropathy.
Am J Gastroenterol, 96 (2001), pp. 1464-1469
Copyright © 2004. Elsevier España, S.L.. Todos los derechos reservados
